Hemochromatosis: A genetic defect in iron metabolism

BioEssays

Volumn 20, Issue 7, 1998, Pages 562-568

  Jazwinska, E C ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONED GENE; GENETIC ANALYSIS; IRON; METABOLISM; MUTATIONAL ANALYSIS; PATHOGENESIS;

ANIMALS; BETA 2-MICROGLOBULIN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; GENETICS, POPULATION; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IRON; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTATION;

EID: 0032128165     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199807)20:7<562::AID-BIES7>3.0.CO;2-M     Document Type: Review

References (59)

1. Harford JB, Rouault TA, Klausner RD (1994) The control of cellular iron homeostasis. In J.H. Brock, J.W. Halliday, M.M. Pippard, and L.W. Powell (eds): Iron Metabolism in Health and Disease. London: W. B. Saunders, pp. 123-149.
2. Vulpe C, Gitschier J (1997) Ironing out anaemia. Nat Genet 16: 319-320.
3. Fleming MD, Trenor CC III, Su MA, Foernzler D, Beier DR, Dietrich W, Frews NC (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16:383-386.
4. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:82-488.
5. Baker E, Morgan EH (1994) Iron transport. In J.H. Brock, J.W. Halliday, M.M. Pippard, and L.W. Powell (eds): Iron Metabolism in Health and Disease. London: W. B. Saunders, pp. 63-95.
6. Aisen P (1994) Iron metabolism: An evolutionary perspective. In J.H. Brock, J. W. Halliday, M.M. Pippard, and L.W. Powell (eds): Iron Metabolism in Health and Disease. London: W. B. Saunders, pp. 1-30.
7. Kuhn LC (1991) mRNA-protein interactions regulate critical pathways in cellular iron metabolism. Br J Haematol 79:1-5.
8. Hentze MW, Rouault RA, Harford JB, Klausner RD (1989) Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 244:357-359.
9. Powell LW, Jazwinska EC, Halliday JW (1994) Primary iron overload. In J. H. Brock, J. W. Halliday, M. J. Pippard, and L. W. Powell (eds): Iron Metabolism in Health and Disease. London: W. B. Saunders, pp. 228-270.
10. Trousseau A (1865) Glycosurie: diabete sucré Clinique Méd de l'Hôtel de Paris 2:663-698
11. Von Reckinghausen FD (1889) Uber Haemochromatose Taggeblatt der (62) Versammlung deutscher Naturforscher und Aerzte in Heidelberg pp 324-325.
12. Pippard MJ (1994) Secondary iron overload. In J. H. Brock, J. W. Halliday, M. J. Pippard and L. W. Powell (eds): Iron Metabolism in Health and Disease London: W. B. Saunders, pp. 271-309.
13. Powell LW, Kerr JFR (1975) The pathology of the liver in hemochromatosis. In J. Joachim (ed): Pathology Annual. New York: Appleton-Century-Crofts, pp. 317.
14. Bassett ML, Halliday JW, Powell LW (1986) Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 6:24-29.
15. Hahn PF, Bale WF, Laurence EO, Whipple GH (1939) Radioactive iron and its metabolism in anaemia. J Exp Med 69:739-753.
16. Crosby WH (1991) A history of phlebotomy therapy for hemochromatosis. Am J Med Sci 301:28-31.
17. Neiderau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Stromeyer G (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313: 1256-1262.
18. Sheldon JH (1935) Haemochromatosis. London: Oxford University Press.
19. Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B (1975) Hémochromatosse idiopathique. Maladie associée à l'antigène tissulaire HL-A3? Nouv Presse Med 4:1432.
20. Jazwinska EC, Pyper WR, Burt MJ, Francis JL, Goldwurm S, Webb SI, Lee SC, Halliday JW, Powell LW (1995) Haplotype analysis in Australian hemochromatosis patients: Evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet 56:428-433.
21. Piperno A, Arosio C, Fargion S, Roetto A, Nicoli C, Girelli D, Sbaiz L, Gasparini P Boari G, Sampietro M, Camaschella C (1996) The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology 24:43-46.
22. Gandon G, Jouanolle AM, Chauvel B, Mauvieux V, le Treut A, Feingold J, Le Gall JY, David V, Yaouang J (1996) Linkage disequilibrium and extended haplotypes in the HLA-A to D6S105 region: Implications for mapping the haemochromatosis gene (HFE) Hum Genet 97:103-113.
23. Raha-Chowdhury R, Bowen DJ, Stone C, Pointon JJ, Terwilliger JD, Shearman JD, Robson KJ, Bomford A, Worwood M (1995) New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet 4:1869-1874.
24. Seese NK, Venditti CP, Chorney KA, Gerhard GS, Ma J, Hudson TJ, Phatak PD, Chorney MJ (1996) Localization of the hemochromatosis disease gene: Linkage disequilibrium analysis using an American patient collection. Blood Cells Mol Dis 22:36-46.
25. Crawford DHG, Halliday JW, Summers KM, Burke M, Powell LW (1993) Concordance of iron storage in siblings with genetic haemochromatosis: Evidence for a predominantly genetic effect on iron storage. Hepatology 17:833-837.
26. Crawford DHG, Powell LW, Leggett BA, Francis JS, Fletcher LM, Webb SI, Halliday JW, Jazwinska EC (1995) Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 57:362-367.
27. Ajioka RS, Jorde LB, Gruen JR, Yu P, Dimitrova D, Barrow J, Radisky E, Edwards CQ, Griffen LM, Kushner JP (1997) Haplotype analysis of haemochromatosis: Evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 60: 1439-1447.
28. Burt MJ, Smit DJ, Pyper WR, Powell LW, Jazwinska EC (1996) A 4.5-Megabase YAC contig and physical map over the hemochromatosis gene region Genomics 33:153-158.
29. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408.
30. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, Walsh TP (1996) Haemochromatotis and HLA-H. Nat Genet 14:249-251.
31. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Carn Grieux N, Gicquel I, Le Gall J-Y, David V (1996) Haemochromatotis and HLA-H. Nat Genet 14:249-251.
32. Mercier B, Mura C, Ferec C (1997) Putting a hold on HLA-H. Nat Genet 15:234.
33. Bodmer JG, Parham P, Albert ED, Marsh SGE (1997) Haemochromatotis and HLA-H. Nat Genet 15:234-235.
34. Bjorkman PJ, Parham P (1990) Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59: 253-288.
35. Ravetch JV, Margulies DH (1994) New tricks for old molecules. Nature 372:323-324.
36. Story CM, Mikulska J, Simister NE (1994) A major histocompatibility complex class I-like fe receptor cloned from human placenta. J Exp Med 180:2377-2381.
37. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, Pockros P, Kosty M, Venditti CP, Phatak PD, Seese NK, Chorney KA, Ten Elshof AE, Gerhard GS, Chorney M (1996) Mutational analysis in hereditary hemochromatosis. Blood Cells Mol Dis 22:187-194.
38. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, Camaschella C (1997) Mutation analysis of the HLA-H gene in Italian haemochromatosis patients. Am J Hum Genet 60:828-832.
39. The UK Haemochromatosis Consortium: A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 41:841, 1997
40. 2-microglobulin interaction and cell surface expression. J Biol Chem 272: 14025-14028.
41. Beutler E (1997) Genetic irony beyond haemochromatosis: Clinical effects of HLA-H mutations. Lancet 349:296-297.
42. Douabin V, Deugnier Y, Jouanolle AM, Moirand R, Macqueron G, Gireau A, Le Gall JY, David V (1997) Polymorphisms in the haemochromatosis gene. Proceedings of the International Symposium: Iron in Biology and Medicine. p267. St Malo.
43. Pointon JJ, Shearman JD, Merryweather-Clarke AT, Robson KJH (1997) A single nucleotide deletion in the putative haemochromatosis gene in a patient who is negative for both the C2823Y and H63D mutations. Proceedings of the International Symposium: Iron in Biology and Medicine. p268. St Malo.
44. Powell LW, Bassett ML, Axelsen E, Ferluga J, Halliday JW (1988) Is all genetic (hereditary) hemochromatosis HLA-associated? Ann NY Acad Sci 526:23-33.
45. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275-278.
46. Simon M, Alexandre JL, Fauchet R, Genetet B, Bourel M (1980) The genetics of haemochromatosis. Prog Med Genet 4:135-138.
47. Smith BN, Kantrowitz W, Grace ND, Greenberg MS, Patton TJ, Ookubo R, Sorger K, Semeraro JG, Doyle JR, Cooper AG, Kamat BR, Maregni LM R, WM (1997) Prevalence of hereditary haemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor? Hepatology 25:1439-1446.
48. Renfrew AC (1987) Archaeology and Language: The Puzzle of Indo-European Origins. London: Johnathan Cape.
49. Logan FD (1991) The Vikings in History, 2nd ed. London: Routledge.
50. Baynes RD (1994) Iron Deficiency. In J. H. Brock, J. W. Halliday, M. J. Pippard, and L. W. Powell (eds): Iron Metabolism in Health and Disease. London: W. B. Saunders, pp. 190-225.
51. 2inf2 Knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sci USA 93: 1529-1534.
52. 2-microglobulin-deficient mice. Immunol Lett 39:105-111.
53. Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, Bacon BR, Sly WS (1994) Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 94:2534-2539.
54. Arce-Gomez B, Jones EA, Barnstable CJ, Solomon E, Bodmer WF (1978) The genetic control of HLA-A and B antigens in somatic cell hybrids: Requirement for beta2 microglobulin. Tissue Antigens 11: 96-112.
55. Seong RH, Clayberger CA, Krensky AM, Parnes JR (1988) Rescue of Daudi cell HLA expression by transfection of the mouse beta 2-microglobulin. J Exp Med 167:288-299.
56. Hsu VW, Yuan LC, Nuchtern JG, Lippincott-Schwartz J, Hammerling GJ, Klausner RD (1991) A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Nature 352:441-444.
57. Jazwinska EC, Powell LW (1997) Hemochromatosis and "HLA-H": Definite! Hepatology 25:495-496.
58. Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ (1995) Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 98:464-468.
59. Adams PC, Gregor JC, Kertesz AE, Valberg LS, (1995) Screening blood donors for hereditary hemochromatosis: Decision analysis model based on a 30-year database. Gastroenterology 109:177-188.